Jonathan Jackson - 02 Sep 2021 Form 4 Insider Report for Histogen Inc.

Role
Director
Signature
/s/ Richard W. Pascoe as attorney-in-fact for Jonathan Jackson
Issuer symbol
N/A
Transactions as of
02 Sep 2021
Net transactions value
$0
Form type
4
Filing time
03 Sep 2021, 16:09:48 UTC
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 02 Sep 2021 Common Stock 20,000 $0.8220 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person, a non-employee director of the Issuer, for his service as a director of the Issuer.
F2 The shares subject to this option become fully vested and exercisable on 5/26/2022, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.